Volume Alert - MYL 55.28 Mylan Inc $MYL Hit a high today of

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - MYL 55.28 Mylan Inc $MYL Hit a high today of 56.08 Closing the day 10:30 at 55.28 -0.96 -1.71% With a day low of 54.72 and a total volume of 1,398,555.

MYL Recent Posts: http://investorshangout.com/Mylan-Inc-MYL-54841/

MYL Mylan Inc Recent Headline News

Next Support Level for Mylan (MYL) is $54.35
Comtex SmarTrend(R) - Wed Nov 19, 9:34AM CST
Shares of Mylan (NASDAQ:MYL) opened today below their pivot of $56.00 and have already reached the first level of support at $55.29. Investors may be interested in a cross of the next downside pivot targets of $54.35 and $52.70.
MYL: 55.72 (-0.52)

Mallinckrodt Q4 Earnings Boosted by Acquisitions, Sales Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 9:07AM CST
Mallinckrodt (MNK) reported adjusted earnings of $1.68 per share in the fourth quarter of fiscal 2014, beating the Zacks Consensus Estimate of $1.34. Earnings were above the year-ago figure of 98 cents per share.
IPXL: 30.00 (+0.46), MNK: 85.56 (-3.24), BIIB: 303.85 (-1.71), MYL: 55.72 (-0.52)

Corium International (CORI) Jumps: Stock Moves 14.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 8:25AM CST
Corium International (CORI) was a big mover last session, with shares rising over 14% on the day.
IPXL: 30.00 (+0.46), CORI: 5.33 (-0.11), AKRX: 38.42 (unch), MYL: 55.72 (-0.52)

Mylan (MYL) Stock: Moving Average Crossover Alert - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 7:48AM CST
Mylan (MYL) Stock: Moving Average Crossover Alert
MYL: 55.72 (-0.52)

Mylan Set to Possibly Pullback After Yesterday's Rally of 2.01%
Comtex SmarTrend(R) - Tue Nov 18, 4:20PM CST
Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $55.05 to a high of $56.70. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $56.25 on volume of 4.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MYL: 55.72 (-0.52)

Zoetis to Buy Abbott's Animal Health Assets for $255 Million - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 4:20PM CST
Zoetis Inc. (ZTS) announced that it has entered into an agreement with Abbott Laboratories to purchase the latter's animal health assets.
ZTS: 43.49 (-0.70), ABT: 43.51 (-0.19), VRX: 141.94 (unch), MYL: 55.72 (-0.52)

Teva wins Actonel patent appeal
Seeking Alpha - at Seeking Alpha - Tue Nov 18, 11:06AM CST

ACT: 268.00 (-1.60), MYL: 55.72 (-0.52), TEVA: 57.23 (unch)

Why Mylan Will Continue To Soar
Main Street Wins - at Seeking Alpha - Tue Nov 18, 8:50AM CST

MYL: 55.72 (-0.52), TEVA: 57.23 (unch)

Is Mallinckrodt (MNK) Poised to Beat Q4 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 4:30PM CST
Mallinckrodt plc (MNK) is set to report fourth-quarter fiscal 2014 results on Nov 19.
IPXL: 30.00 (+0.46), MNK: 85.57 (-3.23), BIIB: 303.85 (-1.71), MYL: 55.72 (-0.52)

Earnings Flashback: Since Reporting Quarterly Results 2 Weeks Ago Mylan Is Up 3.2% (MYL)
Comtex SmarTrend(R) - Mon Nov 17, 2:31PM CST
When Mylan (NASDAQ:MYL) reported earnings 18 days ago on October 30th, 2014, analysts, on average, expected the company to report earnings of $1.14 on sales of $2.1 billion. Mylan actually reported earnings of $1.16 per share on sales of $2.1 billion, beating EPS estimates by $0.02 and beating revenue estimates by $32.3 million. Since the company's report, shares of Mylan have risen from $52.37 to $54.05, representing a gain of 3.2% in the past 18 days.
MYL: 55.72 (-0.52)

AxoGen (AXGN) Looks Good: Stock Adds 5.5% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 8:46AM CST
AxoGen (AXGN) was a big mover last session, with shares rising nearly 6% on the day.
IPXL: 30.00 (+0.46), AXGN: 2.69 (-0.01), AKRX: 38.42 (unch), MYL: 55.72 (-0.52)

InsiderInsights.com Daily Round Up 11/12/14: DVA, PSEC, MRC, SUMR
InsiderInsights - at Seeking Alpha - Fri Nov 14, 3:44PM CST

HAS: 56.27 (+0.15), CJES: 18.24 (+0.26), FB: 73.88 (-0.46), MRC: 21.51 (-0.29), SUMR: 2.80 (-0.03), MYL: 55.72 (-0.52), GOOG: 536.18 (+1.15), GSAT: 2.65 (+0.10), CHRS: 13.19 (+0.03), GGP: 26.25 (+0.34), DVA: 75.04 (-0.19), Q: 57.61 (+0.28), SPW: 92.51 (-0.27), RCPT: 107.54 (+4.56), DATA: 80.45 (-1.65), X: 34.56 (-1.44), PSEC: 9.66 (-0.02), SCHW: 28.52 (-0.24), ERII: 4.89 (-0.01)

Akorn (AKRX) Worth Watching: Stock Adds 6.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 7:51AM CST
Akorn, Inc. (AKRX) was a big mover last session, as its shares rose over 6% on the day.
MNK: 85.53 (-3.27), KBIO: 1.95 (-0.02), AKRX: 38.42 (unch), MYL: 55.72 (-0.52)

Watch for Mylan to Potentially Pullback After Gaining 1.73% Yesterday
Comtex SmarTrend(R) - Thu Nov 13, 4:15PM CST
Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $53.16 to a high of $56.25. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $54.23 on volume of 4.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MYL: 55.72 (-0.52)

Mylan Set to Possibly Pullback After Yesterday's Rally of 1.73%
Comtex SmarTrend(R) - Thu Nov 13, 4:15PM CST
Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $53.16 to a high of $56.25. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $54.23 on volume of 4.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MYL: 55.72 (-0.52)

Trade-Ideas: Mylan (MYL) Is Today's "Barbarian At The Gate" Stock
at The Street - Thu Nov 13, 10:10AM CST
Trade-Ideas LLC identified Mylan (MYL) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
MYL: 55.72 (-0.52)

Big Cap 20 Stuffed With Medical Names
at Investor's Business Daily - Mon Nov 10, 6:34PM CST
Nine of the Big Cap 20 names this week are in medical-related fields, revealing that the leadership among these names over the past few years has continued despite October's correction, which whittled more than 10% off the Nasdaq. Alexion...
ABC: 89.18 (-0.58), VRX: 141.94 (unch), ALXN: 193.31 (+0.94), AMGN: 162.84 (+0.60), MYL: 55.72 (-0.52), ILMN: 190.32 (+0.47), CELG: 107.45 (+0.67)

KaloBios (KBIO) Looks Good: Stocks Adds 11.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 8:25AM CST
KaloBios (KBIO) was a big mover last session, with shares rising over 11% on the day.
MNK: 85.53 (-3.27), IPXL: 30.00 (+0.46), KBIO: 1.95 (-0.02), MYL: 55.72 (-0.52)

Comparing America's 3 Largest Generic Drugs Companies
Joseph Cafariello - at Seeking Alpha - Fri Nov 07, 9:05AM CST

ZTS: 43.48 (-0.71), ACT: 268.00 (-1.60), MYL: 55.72 (-0.52)

Mylan Inc. (MYL) Stock Research Links

MYL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 3

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading
Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 7

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 6

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 6

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 6

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 8

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading

Top 5 Most Recently Viewed Articles

UMeWorld's Next Steps: Innovating Healthier Cooking Oils

Updated Category News Views 116

Transforming Health with Science-Backed Innovations UMeWorld Limited (OTC: UMEWF) is making significant strides in the realm of nutrition and consumer health. Recently, the company unveiled its plans to establish a Product Innovation & Development Center and appointed Dr. Zhang Guangxian to lead this initiative as Chief Scientist. Dr. Zhang, with an impressive two-decade...

Continue Reading
Join Keynode's Exciting 7th Anniversary Staking Event Now

Updated Category News Views 117

Celebrate Keynode's 7th Anniversary with Exclusive Benefits Keynode, a leading crypto staking platform, is thrilled to announce its 7th anniversary. To mark this significant milestone, the platform has launched a limited-time staking event designed to reward all of its users, new and existing, with appealing staking opportunities. This special event invites crypto...

Continue Reading
Columbia Banking System Declares $0.36 Quarterly Dividend

Updated Category News Views 125

Columbia Banking System Declares Quarterly Dividend Columbia Banking System, Inc. (NASDAQ: COLB), the proud parent company of Umpqua Bank, has recently shared some good news with its shareholders. The company’s Board of Directors has officially approved a quarterly cash dividend of $0.36 per common share. This dividend represents a rewarding return for shareholders and...

Continue Reading
Investors Eye META with Unusual Options Activity Trends

Updated Category News Views 218

Understanding Recent Unusual Options Activity in META Recently, there has been a surge in interest surrounding Meta Platforms (NASDAQ: META), as notable investors are showing a bearish approach with their options trading. This activity could influence retail traders and investors alike. Insights from Trading History While the identity of these investors—whether...

Continue Reading
Exploring the Growth Potential of Mobile VoIP Solutions

Updated Category News Views 80

The Promising Future of Mobile VoIP Market Mobile Voice over Internet Protocol (VoIP) market has gained significant momentum, with a valuation of USD 31.2 billion recently. It's projected to surge to an estimated USD 73.4 billion by the end of the decade. As technology continues to evolve and consumer demands shift, this market showcases the increasing preference for...

Continue Reading